United Therapeutics | UTHR - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Amarin USD 3K 5K 2024-12
Ardelyx USD 5.76M 37K 2025-12
Baxter International USD 58M 14M 2025-09
Bayer EUR 675M 87M 2025-12
BioCryst Pharmaceuticals USD 14.14M 5.53M 2025-12
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Esperion Therapeutics USD 22.64M 585K 2025-12
Gilead Sciences USD 240M 15M 2026-03
GlaxoSmithKline GBP 167M 21M 2026-03
Halozyme Therapeutics USD 5.51M 597K 2026-03
Insmed USD 20.08M 517K 2026-03
Ionis Pharmaceuticals USD 17M 1000K 2026-03
J&J USD 43M 25M 2026-03
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Moderna USD 11.49B 36B 2026-03
Omeros USD 4.05M 5.16M 2024-09
Pfizer USD 671M 40M 2026-03
PTC Therapeutics USD 2.87B 2.82B 2026-03
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Sangamo BioSciences 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 20.84M 13.28M 2025-12
Teva Pharmaceutical Industries USD 216M 4M 2026-03
United Therapeutics USD 3.1M 100K 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12